Bayer-Roundup Judge Moves to Resume Cancer Trials in U.S.

(Bloomberg) -- Bayer AG may face as many as four U.S. trials over its Roundup weedkiller next year after a judge said Monday he’s ready to resume putting cases in front of jurors.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.